In contrast, the overexpression of HOXA genes, particularly HOXA9, has been observed concurrently with JAK3 GOF mutations in T-ALL with HOXA9 overexpression co-operating with the JAK3 M511I mutation to elicit a short latency, aggressive leukemia in mice [66]. The gene discussed is JAK3; the disease is leukemia.